Accession Number: | 0001209191-20-030621 |
Date: | 2020-05-18 |
Issuer: | AKCEA THERAPEUTICS, INC. (AKCA) |
Original Submission Date: |
PRICE MICHAEL DENNIS
C/O AKCEA THERAPEUTICS, INC.
22 BOSTON WHARF ROAD, 9TH FLOOR
BOSTON, MA 02210
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2020-05-18 | A | 50,000 | a | $0.00 | 50,000 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 14.78 | 2020-05-18 | deemed execution date | A | 300,000 (a) | 2030-05-17 | common stock 300,000 | $14.78 | 300,000 | direct |
ID | footnote |
---|---|
f1 | represents restricted stock unit award granted under the issuer's 2015 equity incentive plan. |
f2 | the shares vest as follows: 1/4th of the shares vest one year after may 18, 2020; 1/48th of the shares vest monthly thereafter over the next three years. |